Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey

被引:56
|
作者
Kehey, Amy S. [1 ]
Reid, M. Carrington [2 ]
Miller, David H. [3 ]
Fins, Joseph J. [4 ]
Lachs, Mark S. [2 ]
机构
[1] Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA USA
[2] Cornell Univ, Weill Med Coll, Div Geriatr & Gerontol, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Div Cardiol, New York, NY 10021 USA
[4] Cornell Univ, Weill Med Coll, Div Med Eth, New York, NY 10021 USA
关键词
QUALITY-OF-LIFE; CONGESTIVE-HEART-FAILURE; RECIPIENTS; COMPLICATIONS; DECISIONS; PACEMAKER; VIGNETTES; MANAGEMENT; FREQUENCY; DISEASE;
D O I
10.1016/j.ahj.2008.12.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Among older adults, implantable cardioverter-defibrillator (ICD) use is increasing. ICD shocks can occur at end of life (EOL) and cause substantial distress, warranting consideration of ICD deactivation discussions. This nationwide physician survey sought to (1) determine if physicians discuss ICD deactivation at the EOL, (2) identify predictors of those discussions, and (3) ascertain physicians' knowledge/attitudes about ICD use. Methods We surveyed 4,876 physicians stratified by specialty (cardiologists, electrophysiologists, general internists, and geriatricians). The mailed survey presented 5 vignettes leg, end-stage chronic obstructive pulmonary disease, advanced dementia) wherein ICD deactivation might be considered and 17 Likert-scaled items. Results Five hundred fifty-eight (12%) physicians returned surveys. Respondents were largely men (77%) and white (69%). Most physicians (56%-83%) said they would initiate deactivation discussions in all 5 vignettes, whereas significantly more (82%-94%) would discuss advance directives and do not resuscitate status. In logistic regression analyses, a history of prior deactivation discussions was an independent predictor of willingness to discuss deactivation (adjusted OR range, 2.8-8.8) in 4 of the 5 vignettes. General internists and geriatricians were less likely than electrophysiologists. to agree that ICD shocks are painful and to distinguish between the ICD's pacing and defibrillator functions. Finally, most physicians believed that informed consent for ICD implantation should include information about deactivation (77%) and endorsed the need for expert guidance in this area (58%). Conclusions Most physicians would discuss ICD deactivation at EOL. The strongest predictor of this was a history of prior discussions. Knowledge about ICDs varies by specialty, and most expressed a desire for more expert guidance about ICD management at EOL. (Am Heart J 2009; 157:702-8.)
引用
收藏
页码:702 / 708
页数:7
相关论文
共 50 条
  • [1] Deactivation of implantable cardioverter-defibrillator at end of life
    Gradalski, Tomasz
    Smyczynska, Malgorzata
    MEDYCYNA PALIATYWNA-PALLIATIVE MEDICINE, 2015, 7 (03): : 201 - 204
  • [2] Patients' Perspective on Deactivation of the Implantable Cardioverter-Defibrillator Near the End of Life
    Pedersen, Susanne S.
    Chaitsing, Rismy
    Szili-Torok, Tamas
    Jordaens, Luc
    Theuns, Dominic A. M. J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (10): : 1443 - 1447
  • [3] Patients' perception of implantable cardioverter defibrillator deactivation at the end of life
    Hill, Loreena
    McIlfatrick, Sonja
    Taylor, Brian
    Dixon, Lana
    Harbinson, Mark
    Fitzsimons, Donna
    PALLIATIVE MEDICINE, 2015, 29 (04) : 310 - 323
  • [4] IMPLANTABLE CARDIOVERTER - DEFIBRILLATOR DEACTIVATION IN PATIENTS NEARING THE END OF LIFE
    Floria, Mariana
    Rezus, Ciprian
    Ciutea, Mirela Paraschiva
    Ambarus, Valentin
    REVISTA ROMANA DE BIOETICA, 2012, 10 (01) : 134 - 140
  • [5] Lost in Translation Examining Patient and Physician Perceptions of Implantable Cardioverter-Defibrillator Deactivation Discussions
    Mitar, Michael
    Alba, Ana C.
    MacIver, Jane
    Ross, Heather
    CIRCULATION-HEART FAILURE, 2012, 5 (05) : 660 - 666
  • [6] Moral Distress at the End of a Life: When Family and Clinicians Do Not Agree on Implantable Cardioverter-Defibrillator Deactivation
    Steiner, Jill M.
    Patton, Kristen K.
    Prutkin, Jordan M.
    Kirkpatrick, James N.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2018, 55 (02) : 530 - 534
  • [7] PACEMAKER AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DEACTIVATION NEAR END OF LIFE
    Mcloughlin, P.
    Taylor, A.
    Doelman, L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S423 - S423
  • [8] THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - THE END OF THE THORACOTOMY APPROACH
    WELLENS, F
    BRUGADA, P
    GUIRAUDON, G
    DEGRIECK, Y
    DEGEEST, R
    VANERMEN, H
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1994, 8 (12) : 628 - 634
  • [9] Patient Perceptions, Physician Communication, and the Implantable Cardioverter-Defibrillator
    Hauptman, Paul J.
    Chibnall, John T.
    Guild, Camelia
    Armbrecht, Eric S.
    JAMA INTERNAL MEDICINE, 2013, 173 (07) : 571 - 577
  • [10] The implantable cardioverter-defibrillator
    Raj, SR
    Sheldon, RS
    PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 44 (03) : 169 - 194